Arthur Danner - CENTR Brands VP Sales
| 303 Stock | EUR 0.05 0.0002 0.39% |
Insider
Arthur Danner is VP Sales of CENTR Brands Corp
| Phone | 604 733 1514 |
| Web | https://www.findyourcentr.com |
CENTR Brands Management Efficiency
The company has return on total asset (ROA) of (0.9051) % which means that it has lost $0.9051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5149) %, meaning that it generated substantial loss on money invested by shareholders. CENTR Brands' management efficiency ratios could be used to measure how well CENTR Brands manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jing Wang | CanSino Biologics | 42 | |
| Peter Guenter | Merck Company | 61 | |
| Liang Lin | CanSino Biologics | 44 | |
| Franklin Clyburn | Merck Company | 54 | |
| Shinichi Murayama | Hisamitsu Pharmaceutical Co | 56 | |
| Aarti Shah | Elanco Animal Health | 55 | |
| Kimitoshi Usui | Tsumura Co | N/A | |
| Seigo Izumo | Takeda Pharmaceutical | N/A | |
| Shengli Zhong | HANSOH PHARMAC HD 00001 | 51 | |
| Cuifang Ma | HANSOH PHARMAC HD 00001 | 43 | |
| Michael Fleming | Merck Company | 60 | |
| Dongtao Yang | HANSOH PHARMAC HD 00001 | 62 | |
| Zhang Chunbo | Guangzhou Baiyunshan Pharmaceut | 46 | |
| Sheung Chan | HANSOH PHARMAC HD 00001 | 65 | |
| Aifeng Lyu | HANSOH PHARMAC HD 00001 | 42 | |
| Terukazu Kato | Tsumura Co | N/A | |
| Kai Beckmann | Merck Company | 58 | |
| R Hoover | Elanco Animal Health | 73 | |
| Zhu Tao | CanSino Biologics | 46 | |
| Kyu Saito | Hisamitsu Pharmaceutical Co | 60 | |
| Ming Chiu | CanSino Biologics | 42 | |
Management Performance
| Return On Equity | -2.51 | |||
| Return On Asset | -0.91 |
CENTR Brands Corp Leadership Team
Elected by the shareholders, the CENTR Brands' board of directors comprises two types of representatives: CENTR Brands inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CENTR. The board's role is to monitor CENTR Brands' management team and ensure that shareholders' interests are well served. CENTR Brands' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CENTR Brands' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph JD, Founder Director | ||
| David Young, Pres CFO | ||
| Arthur Danner, VP Sales | ||
| Arjan Chima, CEO, Founder |
CENTR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CENTR Brands a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.51 | |||
| Return On Asset | -0.91 | |||
| Operating Margin | (4.85) % | |||
| Current Valuation | 19.09 M | |||
| Shares Outstanding | 97.65 M | |||
| Shares Owned By Insiders | 31.61 % | |||
| Price To Book | 10.01 X | |||
| Price To Sales | 16.52 X | |||
| Revenue | 1.85 M | |||
| Gross Profit | 533.4 K |
Currently Active Assets on Macroaxis
Other Information on Investing in CENTR Stock
CENTR Brands financial ratios help investors to determine whether CENTR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CENTR with respect to the benefits of owning CENTR Brands security.